
Opus Genetics (IRD)
Order type
Buy in
Order amount
Est. shares
0 shares
Buy Opus Genetics (IRD) Stock
Start investing in Opus Genetics (IRD)
About Opus Genetics (IRD)
Market cap | $72.79M |
Yesterday's volume | 9.56K |
Revenue (TTM) | $13.65M |
Avg. daily volume | 1.08M |
EBITDA (TTM) | -$36.27M |
Open | $1.21 |
Price / earnings ratio | -0.63x |
Yesterday's range | $1.14 - $1.22 |
Debt / equity | 371.44x |
52 week range | $0.65 - $2.09 |
5 year debt / equity | 56.05x |
Beta (LTM) | 0.88x |
Interest coverage | — |
Dividend & yield | $0.00 (0.00%) |
Current ratio | 1.98x |
Ex-dividend date | — |
Next earnings | Aug 15, 2025 |
Dividend payable date | — |
Opus Genetics Stock Rating
Opus Genetics Stock News
View all



Frequently Asked Questions (FAQ)
How to buy IRD stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in IRD stock
Navigate to the Explore page. Then, type IRD into the search bar. When you see IRD stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased IRD stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.
Opus Genetics Stock Earnings
The value each IRD share was expected to gain vs. the value that each IRD share actually gained.
Opus Genetics (IRD) reported Q1 2025 earnings per share (EPS) of -$0.24, beating estimates of -$0.29 by 17.24%. In the same quarter last year, Opus Genetics's earnings per share (EPS) was $0. Opus Genetics is expected to release next earnings on 08/15/2025, with an earnings per share (EPS) estimate of -$0.26.